Business

Pharmaceuticals

Reporting and analysis on the Canadian economy, corporate life, banking, energy and the markets.

MarketsBankingEnergyDealsEconomyTechnology
GSK and Sanofi’s Covid shot faces fresh delays as omicron takes holdPharmaceuticalsGSK and Sanofi’s Covid shot faces fresh delays as omicron takes hold
PharmaceuticalsAstraZeneca to sell vaccine for profit after saving one million livesPharmaceuticalsBlackstone bets $250million on London biotech’s next-gen cancer drugPharmaceuticalsGSK shares up as it calls in top scientist to defuse activist attacksPharmaceuticalsBudget 2021: How UK life sciences can build on Covid vaccine successPharmaceuticalsInside the unique $1bn biotech pumping DNA from an old waterworksPharmaceuticalsGSK to quit London HQ as £70bn drugmaker pushes button on splitPharmaceuticalsAstraZeneca buys life sciences pioneer Caelum in $500m dealPharmaceuticalsGlaxoSmithKline bolsters pipeline with two future HIV blockbustersPharmaceuticalsSilence Therapeutics, the biotech on a mission to mute genetic diseasePharmaceuticalsMarlboro maker Philip Morris takes control of asthma inhaler makerPharmaceuticalsThe $3bn British robot start-up shaping the future of surgeryPharmaceuticalsDNA tech firm Oxford Nanopore plots £2.5billion float in London
ADVERTISEMENT